tiprankstipranks
Palvella Therapeutics (PVLA)
NASDAQ:PVLA
US Market
PVLA
Palvella Therapeutics
RESEARCH TOOLSreports
Want to see PVLA full AI Analyst Report?

Palvella Therapeutics (PVLA) Stock News & Sentiment

785 Followers
Palvella Unveils Promising Phase 2 Data for QTORIN
Premium
Company Announcements
Palvella Unveils Promising Phase 2 Data for QTORIN
4d ago
8K
PVLA
Palvella Therapeutics Upgrades Listing to Nasdaq Global Market
Premium
Company Announcements
Palvella Therapeutics Upgrades Listing to Nasdaq Global Market
6d ago
8K
PVLA
Analyst Initiates Buy on Palvella Therapeutics, Citing Differentiated QTORIN Platform and $1B+ Long‑Term Revenue Potential
Premium
Ratings
Analyst Initiates Buy on Palvella Therapeutics, Citing Differentiated QTORIN Platform and $1B+ Long‑Term Revenue Potential
7d ago
PVLA
Palvella Highlights QTORIN Progress and Financing in Q1 Update
Premium
Company Announcements
Palvella Highlights QTORIN Progress and Financing in Q1 Update
12d ago
8K
PVLA
Palvella Therapeutics Adds Independent Dermatology Expert to Board
Premium
Company Announcements
Palvella Therapeutics Adds Independent Dermatology Expert to Board
1M ago
8K
PVLA
Palvella Showcases QTORIN Platform Momentum and Commercial Readiness
Premium
Company Announcements
Palvella Showcases QTORIN Platform Momentum and Commercial Readiness
1M ago
8K
PVLA
3 Best Stocks to Buy Today, 4/1/2026, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Today, 4/1/2026, According to Top Analysts
2M ago
KOD
PVLA
More PVLA News >

PVLA News on the Web

Palvella Unveils Promising Phase 2 Data for QTORIN
TipRanks News
Bullish
Palvella Therapeutics announces new data from TOIVA trial of Qtorin
TipRanks News
Neutral
PVLA’s QTORIN Rapamycin Shows Statistically Significant Bleeding Reduction in Phase 2 TOIVA Study – 100% Patient Satisfaction Highlighted
Market Chameleon
Neutral
Palvella Therapeutics Upgrades Listing to Nasdaq Global Market
TipRanks News
Neutral
Analyst Initiates Buy on Palvella Therapeutics, Citing Differentiated QTORIN Platform and $1B+ Long‑Term Revenue Potential
TipRanks News
Bullish
Palvella Therapeutics initiated with an Overweight at Stephens
TipRanks News
Bullish
Analysts Are Bullish on Top Healthcare Stocks: Argenx Se (ARGX), Protagonist Therapeutics (PTGX)
TipRanks News
Bullish
Palvella Therapeutics Q1 Earnings Call Highlights
MarketBeat
Bullish

News Score - Last 7 Days

Very Positive
PVLA
Sector Average
Media Buzz
This Week5 articles
Weekly Average4 articles
News Sentiment
This Week100%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is PVLA’s Media Buzz Sentiment?
5 articles about PVLA were published this week. In an average week, 4 articles are published.
    What is PVLA’s weekly average amount of articles?
    In an average week, 4 articles about PVLA are published.
      What is PVLA’s News Sentiment?
      100% of articles about PVLA were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week